This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Methoxetamine: Difference between revisions
>Dextromethorphan added effect |
>Sospeedyos Added hole dose visual effect |
||
| Line 26: | Line 26: | ||
==Subjective effects== | ==Subjective effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
{{effects/base | {{effects/base | ||
| Line 63: | Line 64: | ||
====[[Effect::Geometry]]==== | ====[[Effect::Geometry]]==== | ||
The visual geometry found within MXE can be described as very dark and bland when compared to that of [[ketamine]] or [[DXM]] and often consists of many tiny interlocking and woven lines. It does not extend beyond level 4 and can be comprehensively described through its [[Visual_effects:_Geometry#Variations|variations]] as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicolored in scheme, glossy in shading, soft in edges, small in size, slow in speed, smooth in motion, equal in rounded and angular corners, immersive in-depth and consistent in intensity. | The visual geometry found within MXE can be described as very dark and bland when compared to that of [[ketamine]] or [[DXM]] and often consists of many tiny interlocking and woven lines. It does not extend beyond level 4 and can be comprehensively described through its [[Visual_effects:_Geometry#Variations|variations]] as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicolored in scheme, glossy in shading, soft in edges, small in size, slow in speed, smooth in motion, equal in rounded and angular corners, immersive in-depth and consistent in intensity. | ||
High doses entering the "hole" can yield a white glow visual phenomena like ketamine. | |||
====Hallucinatory states==== | ====Hallucinatory states==== | ||
| Line 116: | Line 119: | ||
{{#ask: [[Category:MXE]][[Category:Experience]]|format=ul|Columns=1}} | {{#ask: [[Category:MXE]][[Category:Experience]]|format=ul|Columns=1}} | ||
Additional experience reports can be found here: | Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_Methoxetamine_.shtml Erowid Experience Vaults: MXE] | |||
*[https://www.erowid.org/experiences/subs/exp_Methoxetamine_.shtml Erowid Experience Vaults: MXE] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 142: | Line 146: | ||
Symptoms of ketamine-induced cystitis can become extremely serious and can be described as: | Symptoms of ketamine-induced cystitis can become extremely serious and can be described as: | ||
*'''Urinary frequency''' - Urinary frequency is the need to empty the bladder every few minutes. | *'''Urinary frequency''' - Urinary frequency is the need to empty the bladder every few minutes. | ||
*'''Urinary urgency''' - This can be described as a sudden, compelling need to urinate. | *'''Urinary urgency''' - This can be described as a sudden, compelling need to urinate. | ||
*'''Urinary pressure''' - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. | *'''Urinary pressure''' - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. | ||
| Line 176: | Line 180: | ||
*'''Austria''': Since June 26, 2019, MXE is illegal to possess, produce and sell under the SMG. (Suchtmittelgesetz Österreich)<ref>https://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2019_II_167/BGBLA_2019_II_167.pdfsig</ref> | *'''Austria''': Since June 26, 2019, MXE is illegal to possess, produce and sell under the SMG. (Suchtmittelgesetz Österreich)<ref>https://www.ris.bka.gv.at/Dokumente/BgblAuth/BGBLA_2019_II_167/BGBLA_2019_II_167.pdfsig</ref> | ||
*'''Brazil''': Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344 <ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref> | *'''Brazil''': Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344 <ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref> | ||
*'''Canada''': Health Canada declared MXE a controlled substance, citing it as "considered an analogue of ketamine."<ref>"STATUS DECISION OF CONTROLLED AND NON-CONTROLLED SUBSTANCE(S)", https://web.archive.org/web/20160409135922/http://isomerdesign.com/Cdsa/HC/StatusDecisions/A-2013-00235%20-%20PDFs/C-Methoxetamine-2011-01-31.pdf. Retrieved January 24th, 2017.</ref> The possession, production, and sale are illegal. | *'''Canada''': Health Canada declared MXE a controlled substance, citing it as "considered an analogue of ketamine."<ref>"STATUS DECISION OF CONTROLLED AND NON-CONTROLLED SUBSTANCE(S)", https://web.archive.org/web/20160409135922/http://isomerdesign.com/Cdsa/HC/StatusDecisions/A-2013-00235%20-%20PDFs/C-Methoxetamine-2011-01-31.pdf. Retrieved January 24th, 2017.</ref> The possession, production, and sale are illegal. | ||
*'''Cyprus''': Methoxetamine was listed in the drug control law in 2012.<ref name="JointReport">{{cite journal|issn=1977-7868|isbn=978-92-9168-686-5|doi=10.2810/28543|pages=14-15|title=EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)|url=http://www.emcdda.europa.eu/system/files/publications/818/TDAS14004ENN-1_465208.pdf|date=January 2014|access-date=April 19, 2020|publisher=European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Europol}}</ref> | *'''Cyprus''': Methoxetamine was listed in the drug control law in 2012.<ref name="JointReport">{{cite journal|issn=1977-7868|isbn=978-92-9168-686-5|doi=10.2810/28543|pages=14-15|title=EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)|url=http://www.emcdda.europa.eu/system/files/publications/818/TDAS14004ENN-1_465208.pdf|date=January 2014|access-date=April 19, 2020|publisher=European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Europol}}</ref> | ||
*'''Denmark''': Methoxetamine is covered by the Executive Order on Euphoriant Substances.<ref name="JointReport"/> | *'''Denmark''': Methoxetamine is covered by the Executive Order on Euphoriant Substances.<ref name="JointReport" /> | ||
*'''France''': Methoxetamine was added to the list of illicit substances on August 5, 2013.<ref name="JointReport"/> | *'''France''': Methoxetamine was added to the list of illicit substances on August 5, 2013.<ref name="JointReport" /> | ||
*'''Germany''': MXE is controlled under BtMG Anlage I, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_i.html</ref> | *'''Germany''': MXE is controlled under BtMG Anlage I, making it illegal to manufacture, import, possess, sell, or transfer it without a license.<ref>http://www.gesetze-im-internet.de/btmg_1981/anlage_i.html</ref> | ||
*'''Italy''': According to the table of drugs, MXE has been illegal in Italy since 2016.<ref>http://www.salute.gov.it/imgs/C_17_pagineAree_3729_listaFile_itemName_0_file.pdf</ref> | *'''Italy''': According to the table of drugs, MXE has been illegal in Italy since 2016.<ref>http://www.salute.gov.it/imgs/C_17_pagineAree_3729_listaFile_itemName_0_file.pdf</ref> | ||
| Line 185: | Line 189: | ||
*'''Netherlands''': It is illegal to possess, produce, trasnport, import, export, or sell MXE.<ref>"Opiumwet lijst 1", http://wetten.overheid.nl/BWBR0001941/2017-05-25</ref> | *'''Netherlands''': It is illegal to possess, produce, trasnport, import, export, or sell MXE.<ref>"Opiumwet lijst 1", http://wetten.overheid.nl/BWBR0001941/2017-05-25</ref> | ||
*'''Russia''': It is illegal to possess, produce, or sell MXE.{{citation needed}} | *'''Russia''': It is illegal to possess, produce, or sell MXE.{{citation needed}} | ||
*'''Slovenia''': MXE is a controlled substance (Official Gazette of RS No. 62/2013).<ref name="JointReport"/> | *'''Slovenia''': MXE is a controlled substance (Official Gazette of RS No. 62/2013).<ref name="JointReport" /> | ||
*'''Sweden''': Methoxetamine is controlled under the Narcotic Drugs Control Act (SFS 1992-860) and the Narcotic Drugs Control Ordinance (SFS 1994:1554).<ref name="JointReport"/> | *'''Sweden''': Methoxetamine is controlled under the Narcotic Drugs Control Act (SFS 1992-860) and the Narcotic Drugs Control Ordinance (SFS 1994:1554).<ref name="JointReport" /> | ||
*'''Switzerland:''' MXE is a controlled substance specifically named under Verzeichnis D.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | *'''Switzerland:''' MXE is a controlled substance specifically named under Verzeichnis D.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | ||
*'''Turkey''': Methoxetamine is regulated under the Law on Control of Narcotics no. 2313.<ref name="JointReport"/> | *'''Turkey''': Methoxetamine is regulated under the Law on Control of Narcotics no. 2313.<ref name="JointReport" /> | ||
*'''United Kingdom''': MXE is a Class B drug.{{citation needed}} | *'''United Kingdom''': MXE is a Class B drug.{{citation needed}} | ||
*'''United States''': MXE is not illegal, however, if it is sold with the intention for human consumption (such as in capsules) it becomes illegal to possess under the Federal Analogue Act. This is avoided by placing the label "not for human consumption" on the container of the chemical.{{citation needed}} | *'''United States''': MXE is not illegal, however, if it is sold with the intention for human consumption (such as in capsules) it becomes illegal to possess under the Federal Analogue Act. This is avoided by placing the label "not for human consumption" on the container of the chemical.{{citation needed}} | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research chemical]] | *[[Research chemical]] | ||
| Line 201: | Line 206: | ||
==External links== | ==External links== | ||
*[http://en.wikipedia.org/wiki/Methoxetamine MXE (Wikipedia)] | *[http://en.wikipedia.org/wiki/Methoxetamine MXE (Wikipedia)] | ||
*[https://www.erowid.org/chemicals/methoxetamine/ MXE (Erowid Vault)] | *[https://www.erowid.org/chemicals/methoxetamine/ MXE (Erowid Vault)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=689 MXE (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=689 MXE (Isomer Design)] | ||
===Discussion=== | ===Discussion=== | ||
*[http://www.bluelight.org/vb/threads/524290-The-Big-amp-Dandy-Methoxetamine(2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)-Thread The Big & Dandy Methoxetamine Thread (Bluelight)] | *[http://www.bluelight.org/vb/threads/524290-The-Big-amp-Dandy-Methoxetamine(2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)-Thread The Big & Dandy Methoxetamine Thread (Bluelight)] | ||
==Literature== | ==Literature== | ||
* Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620 | |||
* Halberstadt, A. L., Slepak, N., Hyun, J., Buell, M. R., & Powell, S. B. (2016). The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology, 233(7), 1215-1225. https://doi.org/10.1007/s00213-016-4203-3 | *Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620 | ||
*Halberstadt, A. L., Slepak, N., Hyun, J., Buell, M. R., & Powell, S. B. (2016). The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology, 233(7), 1215-1225. https://doi.org/10.1007/s00213-016-4203-3 | |||
==References== | ==References== | ||